Comparison of Blood Loss Following Total Hip Arthroplasty With the Use of Three Thromboprophylactic Regimes: Dabigatran, Enoxaparin and Rivaroxaban.

Clinical trial NCT02085824 · UNKNOWN

Trial details

NCT number: NCT02085824
Sponsor: Centre of Postgraduate Medical Education
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Hip Osteoarthritis Blood Loss

Start date: 2012-07-01
Primary completion: 2014-04-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.